Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2023-07-04 Capital/Financing Update
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and a subsequent correction (정정신고) for HLB Life Science. It details the terms of the bond issuance, including interest rates, maturity dates, conversion rights, and put options. This falls under the category of capital and financing updates as it relates to the company's debt structure and fundraising activities.
2023-07-04 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a South Korean company (HLB Life Science) regarding the issuance of convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure in the Korean market for significant corporate financing events, which falls under the 'Capital/Financing Update' category.
2023-06-29 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for HLB Life Science Co., Ltd. covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business operations, management discussions, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-12 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming 'Corporate Day' or Investor Relations (IR) event. It provides details such as the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into the specific categories of financial reports or transcripts, it is classified as a regulatory filing announcement regarding an IR event.
2023-05-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including major shareholding notifications, changes in special relationships, and acquisition of stock options. This falls under the 'Major Shareholding Notification' category.
2023-04-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure for insiders (directors, executives, and major shareholders) to report changes in their shareholdings, which falls under the category of 'Director's Dealing' (DIRS).
2023-04-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.